
Analysts Viewpoint
The Attractiveness of Investing In Zentalis Pharmaceuticals Inc (ZNTL) is Growing
Zentalis Pharmaceuticals Inc’s recently made public that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr